Cohance Lifesciences Limited — Dividend/Bonus, 25-04-2025: Record Date

Suven Pharmaceuticals Limited has approved the Scheme of Amalgamation with Cohance Lifesciences Limited, which will be effective from May 1, 2025. The Record Date for allotting shares under this scheme is set for May 8, 2025. Shareholders of Cohance will receive 11 fully paid-up equity shares of Re. 1 each in Suven for every 295 shares of Rs. 10 each they hold. This involves a significant restructuring that may enhance shareholder value and alter the company's equity base.